Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7793 - 7800 of 12086 results
Did You Miss Our Webinar on FTC Enforcement and the Hershey Hospital Merger?
October 3, 2016| Blog| Viewpoint
Five things academic scientists should know when pursuing their first patent - Five-Part Series
October 3, 2016| Blog| Viewpoint
Alleged Wiretap Act and CIPA Violations Held to Satisfy Spokeo Test for Standing in Latest Gmail Privacy Class Action
October 3, 2016| Blog| Viewpoint
Dole Buyers Get Mixed Win In 9th Circ. Natural Label Ruling
October 3, 2016| News
High Court Stays Out Of College Athlete Pay Debate, For Now
October 3, 2016| News
CAFC's Husky Decision Makes Sledding Tougher for Patent Owners in PTAB Appeals
September 30, 2016| Blog| Viewpoint
Proposed USCIS Rule for Entrepreneurs Would Benefit Very Few if Finalized
September 29, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|